CDKN2A and nonpapillary renal cell carcinoma: The TRACERx Renal project identified that deletion of 9p21, including the loss of tumor suppressor cyclin-dependent kinase inhibitor 2A (CDKN2A) is a pivotal event driving the metastasis of ccRCC and related death (49).